1994
DOI: 10.1002/jmv.1890420206
|View full text |Cite
|
Sign up to set email alerts
|

Chronic liver disease in Peru: Role of viral hepatitis

Abstract: The prevalence of antibodies to hepatitis C virus (anti‐HCV) was determined in 105 patients with biopsy‐proven chronic liver disease and 128 comparison patients without any evidence of liver pathology living in Lima, Peru. Using a second‐generation EIA screening and supplemental immunoblot assay, anti‐HCV was detected in four of 13 patients with chronic hepatitis, in 11% of 85 patients with cirrhosis, and in none of seven patients with hepatocellular carcinoma. Only two (1.6%) comparison patients without liver… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 26 publications
0
6
0
Order By: Relevance
“…We found an anti-HCV-positivity prevalence of 39% in cirrhotics and 5% in hospital controls without significant differences between the examined areas. Although these figures are positioned within the range of prevalences reported in the literature (11%-73% in cirrhotics [45][46][47][48][49][50][51][52][53][54] and 0.8%-11% in hospital controls [46][47][48]54,55 ), we cannot exclude an overestimated prevalence because of the use of frozen sera. 56 However, under the assumption that the probability of false positive results is independent of alcohol consumption, this potential bias should not have affected the validity of the results on the joint effect of alcohol and HCV positivity.…”
Section: Discussionmentioning
confidence: 47%
“…We found an anti-HCV-positivity prevalence of 39% in cirrhotics and 5% in hospital controls without significant differences between the examined areas. Although these figures are positioned within the range of prevalences reported in the literature (11%-73% in cirrhotics [45][46][47][48][49][50][51][52][53][54] and 0.8%-11% in hospital controls [46][47][48]54,55 ), we cannot exclude an overestimated prevalence because of the use of frozen sera. 56 However, under the assumption that the probability of false positive results is independent of alcohol consumption, this potential bias should not have affected the validity of the results on the joint effect of alcohol and HCV positivity.…”
Section: Discussionmentioning
confidence: 47%
“…Although these figures are positioned within the range of prevalences reported in the literature (11%-73% in cirrhotics [45][46][47][48][49][50][51][52][53][54] and 0.8%-11% in hospital controls [46][47][48]54,55 ), we cannot exclude an overestimated prevalence because of the use of frozen sera. 56 However, under the assumption that the probability of false positive results is independent of alcohol consumption, this potential bias should not have affected the validity of the results on the joint effect of alcohol and HCV positivity.…”
Section: Discussionmentioning
confidence: 47%
“…In the healthcare setting, patients may serve as a reservoir for transmission, and the prevalence among patients in hospital-related (inpatient and outpatient) settings has been reported to range from 2 to 18% [96][97][98][99] and in chronic hemodialysis settings to average 20%. 82 The few reported episodes of HCV transmission from patient to patient in hospital-related settings have mostly involved unsafe injection practices resulting in contamination of equipment used for phlebotomy or flushing intravenous lines or of multiple dose medication vials.…”
Section: Unsafe Injections and Other Healthcare-related Proceduresmentioning
confidence: 99%